Internal Medicine最新文献_第2页

Intraductal Papillary Neoplasm of the Bile Duct Occurring 37 Years after Surgery for Congenital Biliary Dilatation: A Case Report.

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-19 DOI: 10.2169/internalmedicine.4477-24

Hidehito Sumiya, Daiki Kuboki, Kyohei Ariake, Shinsuke Koshita, Yoshihide Kanno, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Fumisato Kozakai, Haruka Okano, Yuto Matsuoka, Kento Hosokawa, Masaya Oikawa, Takashi Sawai, Yutaka Noda, Kei Ito

引用次数: 0

The Characteristics and Management Considerations of Late-onset Rheumatoid Arthritis. 晚发性类风湿关节炎的特点和管理注意事项。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-02 DOI: 10.2169/internalmedicine.3786-24

Ryusuke Yoshimi, Hideaki Nakajima

引用次数: 0

Hermansky-Pudlak Syndrome with an Improvement in the Respiratory Symptoms after the Administration of Pirfenidone. 服用吡非尼酮后呼吸道症状有所改善的赫尔曼斯基-普德拉克综合征：病例报告。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.3459-24

Yoshinao Ono, Naoki Tode, Yuri Yamamoto, Chikashi Iwasaki, Shuichi Konno, Hatsumi Sugiyama, Takuto Endo, Shunichi Takeda, Shuichiro Matsumoto, Tadahisa Numakura, Tomohiro Ichikawa, Tsutomu Tamada, Hisatoshi Sugiura

引用次数: 0

The Incidence and Influencing Factors of In-hospital Frailty Progression following Transcatheter Aortic Valve Implantation. 经导管主动脉瓣植入术后院内虚弱进展的发生率和影响因素。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.3146-23

Tatsuya Miyazaki, Akihito Tanaka, Yoshiyuki Tokuda, Yoshinori Shirai, Koji Mizutani, Kenji Furusawa, Sho Akita, Takahiro Ozeki, Kiyonori Kobayashi, Hideki Ishii, Masato Mutsuga, Toyoaki Murohara

{"title":"The Incidence and Influencing Factors of In-hospital Frailty Progression following Transcatheter Aortic Valve Implantation.","authors":"Tatsuya Miyazaki, Akihito Tanaka, Yoshiyuki Tokuda, Yoshinori Shirai, Koji Mizutani, Kenji Furusawa, Sho Akita, Takahiro Ozeki, Kiyonori Kobayashi, Hideki Ishii, Masato Mutsuga, Toyoaki Murohara","doi":"10.2169/internalmedicine.3146-23","DOIUrl":"10.2169/internalmedicine.3146-23","url":null,"abstract":"Objective Patients undergoing transcatheter aortic valve implantation (TAVI) are generally older and frailty is therefore an important clinical issue. The baseline degree of frailty is associated with the prognosis in patients undergoing TAVI; however, the incidence of in-hospital frailty progression and its influencing factors have not yet been elucidated. Methods This observational, single-center study retrospectively evaluated 281 patients who underwent TAVI. The degree of frailty at baseline and discharge was evaluated using the Clinical Frailty Scale (CFS). In-hospital frailty progression was defined as an increase of at least one level in the CFS score at discharge from baseline, and predictors of frailty progression were assessed. Results The median baseline CFS score was 4.0 (interquartile range: 3.0-4.0). In-hospital frailty progression was observed in 49 patients (17.4%). No significant differences were observed in age, sex, comorbidities, or surgical risk scores between patients with and without frailty progression. Patients with frailty progression experienced stroke more frequently during hospitalization than those without (12.2% vs. 1.3%, p=0.001). A multivariable logistic analysis showed that in-hospital stroke was a significant predictor of frailty progression (odds ratio, 10.7; 95% confidence interval: 2.34-49.2, p=0.002). Patients with frailty progression had a longer hospital stay than those without frailty progression [7.0 (4.0-17.0) vs. 4.0 (4.0-8.0) days, p=0.001]. Conclusion In-hospital frailty progression was not uncommon in patients undergoing TAVI. Stroke incidence was a significant influencing factor in frailty progression, whereas baseline comorbidities and surgical risks were not.","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"3283-3289"},"PeriodicalIF":1.0,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Subarachnoid Hemorrhaging with Multiple Cerebral Artery Stenoses after Initiating Remission Induction Therapy for Eosinophilic Granulomatosis with Polyangiitis. 嗜酸性粒细胞增多症伴多发性洋炎症启动缓解诱导疗法后出现蛛网膜下腔出血并伴有多处脑动脉狭窄：病例报告。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.3583-24

Haruka Yasuba, Hirotaka Yamada, Masaya Togo, Kento Matoba, Eriko Yamamoto Kashihara, Keisuke Nishimura, Sho Sendo, Yo Ueda, Jun Saegusa

引用次数: 0

Cholesterol Crystal Embolism: Autopsy-proven Gastrointestinal Lesions, Pancreatitis, and End-stage Kidney Disease Which Developed after Undergoing Selective Abdominal Angiography. 胆固醇晶体栓塞：尸检证实接受选择性腹部血管造影术后出现胃肠道病变、胰腺炎和终末期肾病。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.3469-24

Naoki Yamamoto, Norihiko Sakai, Daichi Kaikoi, Daichi Yomogida, Sho Kajikawa, Takaaki Wada, Takahiro Yuasa, Hisayuki Ogura, Koichi Sato, Taro Miyagawa, Shinji Kitajima, Tadashi Toyama, Akinori Hara, Miho Shimizu, Takashi Wada, Yasunori Iwata

引用次数: 0

Type 1 Diabetes Mellitus with Diabetic Ketoacidosis Presenting with Transient Severe Fatty Liver and Subsequent Liver Dysfunction. 一例 1 型糖尿病并发糖尿病酮症酸中毒，表现为一过性严重脂肪肝及随后的肝功能障碍。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.3488-24

Takayuki Suzuki, Kazuki Orime, Ryoichi Akamatsu, Tomoaki Akiyama, Tadashi Yamakawa, Yasuo Terauchi

引用次数: 0

Myasthenic Crisis and Concomitant Takotsubo Syndrome Complicated by Shock. 肌无力危象和休克并发的塔克次氏综合征：病例报告。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.3306-23

Moeko Omiya, Yusuke Morii, Masako Mukai, Yuya Mitsuhashi, Ken Kato, Toshiaki Isogai

引用次数: 0

Clinical Utility of Helicobacter pylori Stool Antigen Testing with a Bioluminescent Enzyme Immunoassay Using a Fecal Occult Blood Test Container. 使用粪便隐血试验容器的生物发光酶免疫测定法检测幽门螺旋杆菌粪便抗原的临床实用性。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.3480-24

Atsushi Imagawa, Sho Takahashi, Katsuhiro Mabe

{"title":"Clinical Utility of Helicobacter pylori Stool Antigen Testing with a Bioluminescent Enzyme Immunoassay Using a Fecal Occult Blood Test Container.","authors":"Atsushi Imagawa, Sho Takahashi, Katsuhiro Mabe","doi":"10.2169/internalmedicine.3480-24","DOIUrl":"10.2169/internalmedicine.3480-24","url":null,"abstract":"Objective A dedicated stool container is required for Helicobacter pylori stool antigen testing. If H. pylori fecal antigen can be measured from a fecal occult blood test container (S fecal collection container or S container), which is widely used for colorectal cancer screening, screening of the upper and lower gastrointestinal tract can be performed with a single stool sample. We investigated the clinical usefulness of an H. pylori stool antigen assay using an S container. Materials A total of 347 patients who underwent esophagogastroduodenoscopy (EGD) were included. After the procedure, H. pylori stool antigen was measured using the S container and collection container recommended for H. pylori stool antigen (BL-stool collection container or BL container), and the qualitative outcomes of each were compared. A bioluminescent enzyme immunoassay (BLEIA) was used to measure H. pylori stool antigen. Results The overall agreement between S containers and BL containers was 100% (347/347), indicating that the qualitative outcomes were equivalent. As a secondary analysis, the results of the S container samples were evaluated according to the diagnosis made by physicians, and the overall agreement rate was 99.7% (345/346), indicating a high correlation. Conclusion The detection of H. pylori stool antigen using the S container is clinically useful because the results are equivalent to those obtained by the usual method. Screening of the upper and lower gastrointestinal tract is expected to be possible with a single stool sample in the future.","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"3271-3275"},"PeriodicalIF":1.0,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Steroid Therapy for Patients with Septic Shock: A Multicenter Observational Study Conducted in Japan. 脓毒性休克患者的类固醇治疗：日本一项多中心观察研究。

IF 1 4区医学

Internal Medicine Pub Date : 2024-12-15 Epub Date: 2024-05-09 DOI: 10.2169/internalmedicine.1511-22

Maki Murata, Sayaka Shimizu, Ryohei Yamamoto, Tsukasa Kamitani, Hajime Yamazaki, Yusuke Ogawa, Shunichi Fukuhara, Hideto Yasuda, Yosuke Yamamoto

{"title":"Steroid Therapy for Patients with Septic Shock: A Multicenter Observational Study Conducted in Japan.","authors":"Maki Murata, Sayaka Shimizu, Ryohei Yamamoto, Tsukasa Kamitani, Hajime Yamazaki, Yusuke Ogawa, Shunichi Fukuhara, Hideto Yasuda, Yosuke Yamamoto","doi":"10.2169/internalmedicine.1511-22","DOIUrl":"10.2169/internalmedicine.1511-22","url":null,"abstract":"Objective The Clinical Practice Guidelines for the Management of Sepsis and Septic Shock weakly recommend steroids for septic shock resistant to fluid resuscitation and vasopressors. This study aimed to describe the clinical practices for septic shock in the real world and to compare the association between the intermittent or continuous infusion of steroids and the prognosis. Methods This was a retrospective cohort study based on the AMOR-VENUS, in which Japanese intensive care unit (ICU) inpatients were enrolled between January and March 2018. Adult patients with sepsis who received vasopressors within 72 h of ICU admission were included. The patients were divided into non-steroid and steroid groups, which were further divided into intermittent and continuous infusion groups. The patient characteristics and details of the steroids are described. To investigate the association between intermittent or continuous infusion, shock reversal, and mortality, logistic regression analyses were performed after adjusting for possible confounding factors. Results A total of 180 patients with septic shock from 18 ICUs were enrolled. The mean age was 69.6 (standard deviation, 14.3) years. Sixty-three patients (35.0%) received steroids (26 intermittently, 37 continuously). In the steroid group, hydrocortisone was used in 85.7%, the median daily dose was 192 mg, and the steroids were administered within 6 h of initiating vasopressor in 71.4%. The adjusted odds ratios of shock reversal on the 7th day and the ICU mortality for continuous versus intermittent infusion were 1.90 (95% confidence interval, 0.43-8.40) and 0.61 (0.10-3.85), respectively. Conclusion There was considerable variation in the criteria for the selection of patients and in the decision to use continuous or intermittent steroid infusion.","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"3307-3315"},"PeriodicalIF":1.0,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0